GMO US Quality ETF
QLTY
149 hedge funds and large institutions have $2.98B invested in GMO US Quality ETF in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 28 reducing their positions, and 9 closing their positions.
193% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 28
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
23% more capital invested
Capital invested by funds: $2.43B → $2.98B (+$555M)
4% more funds holding
Funds holding: 143 → 149 (+6)
3.16% more ownership
Funds ownership: 80.58% → 83.74% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 19 → 19 (0)
Top Buyers
Top Sellers
QLTY Hedge Fund Activity: Q1 2026 in Review
149 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in GMO US Quality ETF (QLTY) for Q1 2026, worth a combined $2.98B — up 23% from $2.43B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new QLTY positions and 9 closed out — a net gain of 8 holders — while 82 added to existing stakes and 28 trimmed.
The largest buyer was Brown Brothers Harriman & Co, adding an estimated $224M. The largest seller was Wealth Enhancement Advisory Services, cutting an estimated $11.3M.
- 149 institutional investors held GMO US Quality ETF (QLTY) as of Q1 2026, up from 143 in Q4 2025.
- Funds reported $2.98B of GMO US Quality ETF stock for Q1 2026, up 23% quarter-over-quarter.
- 17 funds opened new GMO US Quality ETF positions in Q1 2026 and 9 closed out, a net change of +8 holders.
- The largest GMO US Quality ETF buyer in Q1 2026 was Brown Brothers Harriman & Co, an estimated $224M added.
- The largest GMO US Quality ETF seller in Q1 2026 was Wealth Enhancement Advisory Services, an estimated $11.3M sold.
Based on aggregated 13F filings for Q1 2026.